1. Home
  2. HUT vs GKOS Comparison

HUT vs GKOS Comparison

Compare HUT & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hut 8 Corp.

HUT

Hut 8 Corp.

N/A

Current Price

$91.63

Market Cap

9.8B

Sector

Finance

ML Signal

N/A

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$168.70

Market Cap

10.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HUT
GKOS
Founded
2011
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.8B
10.6B
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
HUT
GKOS
Price
$91.63
$168.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
12
Target Price
$65.20
$126.92
AVG Volume (30 Days)
4.6M
573.4K
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$235,118,000.00
$507,442,000.00
Revenue This Year
$161.69
$23.32
Revenue Next Year
N/A
$27.43
P/E Ratio
N/A
N/A
Revenue Growth
44.79
32.33
52 Week Low
$31.67
$73.16
52 Week High
$140.80
$191.62

Technical Indicators

Market Signals
Indicator
HUT
GKOS
Relative Strength Index (RSI) 47.62 45.52
Support Level $73.55 $96.44
Resistance Level $94.22 $184.68
Average True Range (ATR) 6.43 6.22
MACD 1.36 -2.25
Stochastic Oscillator 44.42 31.38

Price Performance

Historical Comparison
HUT
GKOS

About HUT Hut 8 Corp.

Hut 8 Corp is an energy infrastructure platform that integrates power, digital infrastructure, and compute at scale to fuel next-generation, energy-intensive use cases. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: